Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special Reports
The top 10 drugs losing US exclusivity in 2026
While megablockbusters naturally command significant attention, Fierce takes a chance each year to look at older medicines nearing their tumble over the patent cliff.
Eric Sagonowsky
,
Fraiser Kansteiner
,
Kevin Dunleavy
,
Zoey Becker
Mar 16, 2026 3:00am
Fierce Madness Drug Name Tournament 2026: 1st round now open
Mar 17, 2026 6:00am
Md. bill calls for transparency in disease awareness campaigns
Mar 19, 2026 12:04pm
Corium sells off ADHD drug Azstarys to Collegium for $650M-plus
Mar 19, 2026 11:27am
After Alfasigma licensing deal, Lynavoy picks up FDA nod
Mar 19, 2026 10:55am
AZ to build cell therapy supply hub, R&D center in Shanghai
Mar 19, 2026 10:20am
More News
Regulatory tracker: Sarepta proceeds with DMD conversion bids
Mar 19, 2026 9:15am
Pfizer eyes earlier Talzenna use after ph. 3 prostate cancer win
Mar 19, 2026 6:45am
Lilly's shares have dropped by 7% since HSBC downgrade
Mar 18, 2026 3:36pm
TrumpRx's 'world's lowest' drug prices called into question: NYT
Mar 18, 2026 3:36pm